New Zealand markets open in 2 hours 14 minutes

MRNA Jan 2024 105.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
20.150.00 (0.00%)
As of 03:12PM EDT. Market open.
Full screen
Previous close20.15
Open20.19
Bid18.10
Ask19.45
Strike105.00
Expiry date2024-01-19
Day's range20.15 - 20.45
Contract rangeN/A
Volume5
Open interest448
  • Editor's pick
    Yahoo Finance

    Omicron: Experts want more data to guide US targeting of fall boosters

    The FDA is asking COVID-19 vaccine makers to test and produce boosters that target both the original and new BA.4/BA.5 strains of the virus by fall.

  • Motley Fool

    Could This Send Moderna's Stock Soaring Back to $400?

    Shares of Moderna (NASDAQ: MRNA) have been plummeting in recent months. As concerns shift from COVID-19 and onto inflation, investors have become less bullish on Moderna's stock. Omicron was a significant variant when it emerged in November, and that prompted Moderna to create a booster shot which targeted that variant.

  • Motley Fool

    3 Things About Moderna That Smart Investors Know

    Prior to the pandemic, Moderna (NASDAQ: MRNA) was like many other small biotechs. In fact, for the full year of 2019, Moderna had only $60 million in revenue, entirely from collaborations and grants, and it posted a net loss of $514 million. As we know, Moderna's ability to rapidly produce a vaccine for the COVID-19 virus changed the financial prospects for the company and put it in a completely different position today.